Ping Zhang's Stock Option Grant in Gyre Therapeutics, Inc.

On August 5, 2025, Ping Zhang, a director of Gyre Therapeutics, Inc., was granted a stock option to purchase 250,000 shares of the company's common stock at an exercise price of $6.92 per share. The option vests over four years, with 25% vesting on August 5, 2026, and the remaining 75% vesting in equal monthly installments over the following three years. The option expires on August 5, 2035. This transaction was reported in a Form 4 filing with the SEC. The grant is subject to Zhang's continued service with the company through each vesting date. The transaction increases Zhang's total holdings in Gyre Therapeutics to 250,000 shares.